Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Senior Fellow, Hematology / Oncology, Duke Universitymedical Center, Duke University 2016 - 2019
  • Internal Medicine Residency, Duke University Medical Center, Duke University 2013 - 2016
  • M.D., University of Cincinnati, College of Medicine 2013
  • B.S., Miami University, Hamilton 2006
• 

  Medical Licensure

  • 2019-01277. North Carolina. 2019
• Expertise
• 

  Subject Headings

  • Cancer
  • Chronic lymphocytic leukemia
  • Lymphoma
  • Lymphomas
  • Survivorship
• Research
• 

  Selected Grants

  • DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PROSPECTIVE PHASE III STUDY EVALUATING EFFICACY AND SAFETY OF PANZYGA IN PRIMARY INFECTION PROPHYLAXIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA ("PRO-SID" study) awarded by Octapharma AG 2020 - 2025
  • A Multicenter, Open-Label, Single-Arm, Phase 2 Study of ME-401 in Subjects with Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies awarded by MEI Pharma, Inc. 2020 - 2025
  • Exercise training to promote improved immune resilience in adults with chronic lymphocytic leukemia - a randomized control trial awarded by  American Society of Hematology 2020 - 2022
• 

  External Relationships

  • Agios
  • Agios Pharmaceuticals
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Eyre, Toby A., Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, et al. “Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.” Haematologica 106, no. 1 (January 1, 2021): 284–87. https://doi.org/10.3324/haematol.2019.241539.
       Full Text  Link to Item
    • Roeker, Lindsey E., Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, et al. “Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.” Blood Adv 4, no. 16 (August 25, 2020): 3977–89. https://doi.org/10.1182/bloodadvances.2020001956.
       Full Text  Link to Item
    • Mato, Anthony R., Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle Brander, Mazyar Shadman, et al. “Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.” Clin Cancer Res 26, no. 14 (July 15, 2020): 3589–96. https://doi.org/10.1158/1078-0432.CCR-19-3815.
       Full Text  Link to Item
    • Sitlinger, Andrea, Danielle M. Brander, and David B. Bartlett. “Impact of exercise on the immune system and outcomes in hematologic malignancies.” Blood Adv 4, no. 8 (April 28, 2020): 1801–11. https://doi.org/10.1182/bloodadvances.2019001317.
       Full Text  Link to Item
    • Roeker, Lindsey E., Christopher P. Fox, Toby A. Eyre, Danielle M. Brander, John N. Allan, Stephen J. Schuster, Chadi Nabhan, et al. “Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.” Clin Cancer Res 25, no. 14 (July 15, 2019): 4264–70. https://doi.org/10.1158/1078-0432.CCR-19-0361.
       Full Text  Link to Item
    • Mato, Anthony R., Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, et al. “A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.” Blood Adv 3, no. 10 (May 28, 2019): 1568–73. https://doi.org/10.1182/bloodadvances.2019000180.
       Full Text  Link to Item
    • Ortel, Thomas L., Katie Arnold, Michele Beckman, Audrey Brown, Nimia Reyes, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh, Andrea Sitlinger, and Elizabeth H. Thames. “Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.” Appl Clin Inform 10, no. 3 (May 2019): 552–62. https://doi.org/10.1055/s-0039-1693711.
       Full Text  Link to Item
    • Sitlinger, Andrea, Rebecca A. Shelby, Alyssa N. Van Denburg, Heidi White, Sarah N. Edmond, Paul K. Marcom, Hayden B. Bosworth, Francis J. Keefe, and Gretchen G. Kimmick. “Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.” J Geriatr Oncol 10, no. 2 (March 2019): 317–21. https://doi.org/10.1016/j.jgo.2018.11.008.
       Full Text  Link to Item
    • Sitlinger, Andrea, and Syed Yousuf Zafar. “Health-Related Quality of Life: The Impact on Morbidity and Mortality.” Surg Oncol Clin N Am 27, no. 4 (October 2018): 675–84. https://doi.org/10.1016/j.soc.2018.05.008.
       Full Text  Link to Item
    • Mato, Anthony R., Meghan Thompson, John N. Allan, Danielle M. Brander, John M. Pagel, Chaitra S. Ujjani, Brian T. Hill, et al. “Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.” Haematologica 103, no. 9 (September 2018): 1511–17. https://doi.org/10.3324/haematol.2018.193615.
       Full Text  Link to Item
    • Sitlinger, Andrea Phillips, and S Yousuf Zafar. “With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern.” Dis Colon Rectum 61, no. 1 (January 2018): 4–5. https://doi.org/10.1097/DCR.0000000000000922.
       Full Text  Link to Item
    • Sitlinger, A. P., C. J. Lindsell, A. H. Ruffner, D. B. Wayne, K. W. Hart, A. T. Trott, C. J. Fichtenbaum, and M. S. Lyons. “Preliminary program evaluation of emergency department HIV prevention counseling.” Annals of Emergency Medicine 58, no. 1 SUPPL. (January 1, 2011). https://doi.org/10.1016/j.annemergmed.2011.03.036.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.